Introducing The Global FSHD Innovation Hub
The Hub is owned by the FSHD Society, and its mission is to provide a singular global end-to-end offering for biopharma companies to accelerate their products for FSHD and get these potential new treatments to people faster. The Hub evolved through the global vision and leadership of the FSHD Society, and is a formal partnership among the FSHD Society, TRiNDS, and Lumiio.